#7: TheMachine: ALXN Stock News : Alexion Submits NDA in Japan for Soliris(R) (eculizumab) as a Treatment for Patients with PNH
Alexion Pharmaceuticals, Inc., (Nasdaq: ALXN) today announced that it
... |
May 25, 2009
11:28:12 PM |
#6: TheMachine: Alexion to Present at the UBS Global Life Sciences Conference
CHESHIRE, Conn., Sept. 16 /PRNewswire/ --... |
September 20, 2008
02:05:20 AM |
#5: TheMachine: Semi-annual Changes to the NASDAQ Q-50 Index
NEW YORK, Sept. 15, 2008 (GLOBE NEWSWIRE) -- The NASDAQ OMX... |
September 20, 2008
02:05:00 AM |
#4: Stock News Bot: ALXn Stock: Alexion to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Alexion to Present at the Morgan Stanley Global Healthcare Unplugged Conference
... |
September 4, 2008
06:04:56 PM |
#3: Stock News Bot: Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
CHESHIRE, Conn., March 20 /PRNewswire-FirstCall/ -- Alexion
Pharmaceuticals, Inc.... |
April 13, 2008
03:50:32 PM |
#2: FastFun: Alexion Pharmaceuticals to Present Data on Soliris(R) (Eculizumab) and PNH at the 2007 American Society of Hematology (ASH) Annual Meeting
CHESHIRE, Conn., Nov. 9 /PRNewswire-FirstCall/ -- Alexion... |
November 27, 2007
10:27:09 PM |
#1: Stock News Bot: ALXN News William Blair & Company Initiates Coverage of Alexion Pharmaceuticals, Inc. With Outperform Rating
CHICAGO--(BUSINESS WIRE)--William Blair & Company initiated research coverage... |
March 7, 2007
06:15:00 AM |
